BusinessMerck Raises 2026 Earnings Outlook After Keytruda Qlex Sales Beat EstimatesBy Helena WardOct 29, 2026, 1:16 PM UTC
BusinessGalectin Therapeutics to Present at 2nd Annual NASH Summit 2018By Nasdaq OMXApr 18, 2018, 12:00 PM UTC
BusinessGalectin Therapeutics to Present Late-Breaker Oral Presentation at The International Liver Congress 2018By Nasdaq OMXApr 4, 2018, 1:00 PM UTC
BusinessGalectin Therapeutics Reports 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXMar 29, 2018, 12:10 PM UTC
BusinessGalectin Therapeutics to Present at Two International Conferences in MarchBy Nasdaq OMXMar 9, 2018, 1:30 PM UTC
BusinessGalectin Therapeutics to Present at 2nd Annual H.C. Wainwright NASH Investor ConferenceBy Nasdaq OMXMar 8, 2018, 1:31 PM UTC
BusinessGalectin Therapeutics to Present at 30th Annual ROTH ConferenceBy Nasdaq OMXFeb 28, 2018, 9:35 PM UTC
BusinessGalectin Therapeutics to Present at BIO CEO & Investor ConferenceBy Nasdaq OMXFeb 6, 2018, 2:15 PM UTC
